Digital Health is growing at an extremely fast rate and FDA is striving to encourage digital health innovation while protecting the public health. Learn how FDA regulates the wide range of digital health products and the initiatives the agency has launched to keep pace with this field.
Presenter: Stephanie Philbin
Stephanie Philbin is a counsel in Goodwin’s Life Sciences practice and a member of its FDA group. Philbin concentrates her practice on Food and Drug Administration laws, advising medical device clients on regulatory and compliance issues. She also advises investors in FDA-regulated companies, including drug and biotech companies.
To view the webinar replay, please click the link below and complete the information. You will receive an email with a link to the webinar.WATCH NOW